Executives
-
Guindo ChirfiChief Marketing Officer -
Smart DaltonSVP Fin. - Global Controller
-
Deluca Richard R.EVP&Pres, Merck Animal Heallth
-
Oosthuizen Johannes JacobusPresident, U.S. Market
-
Larson Betty DEVP, Chief HR Officer
-
Downing Cristal NChief Comm. & Public Afrs Ofcr
-
Zachary JenniferEVP, General Counsel
-
Li Dean YExecutive VP & President, MRL
-
Davis Robert MChairman, CEO & President
-
Chattopadhyay SanatExe V-P & Pres. MMD
-
Williams David MichaelEVP,Chief Info&Digital Officer
-
Litchfield CarolineEVP & CFO
-
Mizell StevenEVP, Chief HR Officer
?
Mizell Steven
EVP, Chief HR Officer
Merck & Co., Inc.
US, Kenilworth [HQ]
CIK
1189403
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
41,319,145
Price per Share :
$100.03
Equivalence :
$4,133,154,074.35
Transaction History
-
A41,319,145 Shares After TransactionValue : $4,934,745,487.35$2,195,601.12Transaction Date : 01/22/24
-
Footnotes
-
-
Footnotes:#1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.
-
M42,143,145 Shares After TransactionValue : $2,979,941,782.95$58,265.04Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
-
M74,313,145 Shares After TransactionValue : $5,479,108,180.85$2,371,894.10Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
-
S23,619,145 Shares After TransactionValue : $2,991,364,714.25Sold $6,420,395.10Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
-
A533 Shares After TransactionValue : $n/a$0.0Transaction Date : 01/02/25
-
Footnotes
-
-
Footnotes:No footnote found.